Similar articles

• Development of novel oestrogen-receptor antagonists.

  Wakeling AE, Bowler J. Wakeling AE, et al. Biochem Soc Trans. 1991 Nov;19(4):899-901. doi: 10.1042/bst0190899. Biochem Soc Trans. 1991. PMID: 1794580 Review. No abstract available.
• Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.

  Lykkesfeldt AE, Madsen MW, Briand P. Lykkesfeldt AE, et al. Cancer Res. 1994 Mar 15;54(6):1587-95. Cancer Res. 1994. PMID: 8137264
• The potential for a novel pure anti-oestrogen.

  Wakeling AE. Wakeling AE. Horm Res. 1989;32 Suppl 1:257-9; discussion 260. doi: 10.1159/000181359. Horm Res. 1989. PMID: 2613211
• Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.

  Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS. Montano MM, et al. Mol Endocrinol. 1996 Mar;10(3):230-42. doi: 10.1210/mend.10.3.8833652. Mol Endocrinol. 1996. PMID: 8833652
• Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer.

  Nicholson RI, Gee JM, Manning DL, Wakeling AE, Montano MM, Katzenellenbogen BS. Nicholson RI, et al. Ann N Y Acad Sci. 1995 Jun 12;761:148-63. doi: 10.1111/j.1749-6632.1995.tb31376.x. Ann N Y Acad Sci. 1995. PMID: 7625718 Review. No abstract available.